Clinical Trial Update: Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of AZD1480 in adults with myeloproliferative diseases has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• AZD1480

Snippet

Sponsor: AstraZeneca | Conditions: Primary Myelofibrosis (PMF), Post-Polycythaemia Vera | Phase 1 | Status: COMPLETED | Results posted: 2017-04-24